# MYRIAD GENETICS INC (MYGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from MYRIAD GENETICS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MYGN/mda/fy2025/): filed 2026-02-24; accession 0000899923-26-000018 (https://www.sec.gov/Archives/edgar/data/899923/000089992326000018/mygn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MYGN/mda/fy2024/): filed 2025-02-28; accession 0000899923-25-000019 (https://www.sec.gov/Archives/edgar/data/899923/000089992325000019/mygn-20241231.htm)
- [FY 2023 MD&A](/company/MYGN/mda/fy2023/): filed 2024-02-28; accession 0000899923-24-000018 (https://www.sec.gov/Archives/edgar/data/899923/000089992324000018/mygn-20231231.htm)
- [FY 2022 MD&A](/company/MYGN/mda/fy2022/): filed 2023-03-01; accession 0000899923-23-000011 (https://www.sec.gov/Archives/edgar/data/899923/000089992323000011/mygn-20221231.htm)
- [FY 2021 MD&A](/company/MYGN/mda/fy2021/): filed 2022-02-25; accession 0000899923-22-000033 (https://www.sec.gov/Archives/edgar/data/899923/000089992322000033/mygn-20211231.htm)

Back to /company/MYGN/